CLL Cells Respond to B-Cell Receptor Stimulation with a MicroRNA/mRNA Signature Associated with MYC Activation and Cell Cycle Progression-Reference-Cited by-同舟云学术

CLL Cells Respond to B-Cell Receptor Stimulation with a MicroRNA/mRNA Signature Associated with MYC Activation and Cell Cycle Progression

Published:2013-04-01 Issue:4 Volume:8 Page:e60275
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pede Valerie,Rombout Ans,Vermeire Jolien,Naessens Evelien,Mestdagh Pieter,Robberecht Nore,Vanderstraeten Hanne,Van Roy Nadine,Vandesompele Jo,Speleman Frank,Philippé Jan,Verhasselt Bruno

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. Chronic lymphocytic leukemia;N Chiorazzi;N Engl J Med,2005

2. Prognostic markers in chronic lymphocytic leukemia: A comprehensive review;F Van Bockstaele;Blood Reviews,2009

3. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile;A Wiestner;Blood,2003

4. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence;N Darzentas;Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK,2010

5. Antigens in chronic lymphocytic leukemia–implications for cell origin and leukemogenesis;A Rosen;Sem Cancer Biol,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia;Blood;2024-08-01

2. Multiple omics levels of chronic lymphocytic leukemia;Cell Death Discovery;2024-06-21

3. Metabolic reprogramming in the CLL TME; potential for new therapeutic targets;Seminars in Hematology;2024-06

4. BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway;Blood;2021-12-09

5. Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential;International Journal of Molecular Sciences;2021-08-31